Molecular genetic aspects of the phakomatoses: tuberous sclerosis complex and neurofibromatosis 1

被引:12
|
作者
MacCollin, M
Kwiatkowski, D
机构
[1] Massachusetts Gen Hosp, Neurol Serv, Charlestown, MA USA
[2] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
关键词
D O I
10.1097/00019052-200104000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The phakomatoses are a diverse group of diseases characterized by skin lesions in early childhood followed by the development of tumors in many other organs. Tuberous sclerosis complex and neurofibromatosis 1 are of special interest to the neurologist because of their prominent neuro-oncological and neuro-developmental consequences. The cloning of genes responsible for these two diseases has led to the identification of causative mutations. an understanding of basic cellular pathophysiology and the development of animal models. Current laboratory investigations are focused on bringing clinical relevance to these findings, including the prospects of molecular diagnostics and rational therapeutics. Curr Opin Neurol 14:163-169. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 50 条
  • [31] Tuberous sclerosis complex with concurrent neurofibromatosis type 1. Effect of a rapamycin therapy on the course of epilepsy
    Wiemer-Kruel, A.
    Mayer, K.
    Staehler, M.
    Linsenmaier, U.
    Fahrbach, J.
    Weber, L.
    Fischereder, M.
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2010, 23 (01): : 6 - 12
  • [32] Growing Up With Neurofibromatosis Type 1 and Tuberous Sclerosis Complex: Concerns and Care Needs of Young Adults
    Rietman, A.
    van Helden, H.
    Both, P.
    ten Holt, L. S.
    ten Hoopen, L.
    Patist, J.
    Vergeer, A. H. M.
    Moll, H.
    Mous, S. E.
    ten Hoopen, L. W.
    de Heus, G. C. B.
    de Wit, M. C. Y.
    Oostenbrink, R.
    Van Eeghen, Agnies M.
    JOURNAL OF MENTAL HEALTH RESEARCH IN INTELLECTUAL DISABILITIES, 2017, 10 : 116 - 117
  • [33] Genetic Modifiers of Disease Severity in Tuberous Sclerosis Complex
    Sanchez-Castillo, M.
    Rangasamy, S.
    Ramsey, K.
    Sekar, S.
    Adkins, J.
    Cuyugan, L.
    Monheim-Janss, C.
    Sankaramoorthy, A.
    Kaneshamoorthy, S.
    Swaminathan, P.
    Aziz, A-M
    Narayanan, V
    ANNALS OF NEUROLOGY, 2023, 94 : S107 - S107
  • [34] Genetic analysis of 18 families with tuberous sclerosis complex
    Yin, Kaili
    Lin, Nan
    Lu, Qiang
    Jin, Liri
    Huang, Yan
    Zhou, Xiangqin
    Xu, Kaifeng
    Liu, Qing
    Zhang, Xue
    NEUROGENETICS, 2022, 23 (03) : 223 - 230
  • [35] Genetic analysis of 18 families with tuberous sclerosis complex
    Kaili Yin
    Nan Lin
    Qiang Lu
    Liri Jin
    Yan Huang
    Xiangqin Zhou
    Kaifeng Xu
    Qing Liu
    Xue Zhang
    neurogenetics, 2022, 23 : 223 - 230
  • [36] Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome
    Tang, Y
    Schapiro, MB
    Franz, DN
    Patterson, BJ
    Hickey, FJ
    Schorry, EK
    Hopkin, RJ
    Wylie, M
    Narayan, T
    Glauser, TA
    Gilbert, DL
    Hershey, AD
    Sharp, FR
    ANNALS OF NEUROLOGY, 2004, 56 (06) : 808 - 814
  • [37] Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex
    Salussolia, Catherine L.
    Klonowska, Katarzyna
    Kwiatkowski, David J.
    Sahin, Mustafa
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 20, 2019, 2019, 20 : 217 - 240
  • [38] Clinical and genetic aspects of neurofibromatosis 1
    Jett, Kimberly
    Friedman, Jan M.
    GENETICS IN MEDICINE, 2010, 12 (01) : 1 - 11
  • [40] Molecular pathogenesis of tuber formation in tuberous sclerosis complex
    Crino, PB
    JOURNAL OF CHILD NEUROLOGY, 2004, 19 (09) : 716 - 725